Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
| Image |  |
|---|---|
| Description | scientific article published on 18 December 2018 |
| Author/s |
author: Lillian Siu Ulrich Keilholz |
| Publication date | December 18, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |